Researchers draw from a large retrospective review to visually show how sex-related differences in the causes of surgically treated mitral valve disease have persisted over the past quarter century.
The COAPT trial finds transcatheter mitral valve repair to be safe and highly effective in a setting with no good treatment options: symptomatic mitral regurgitation secondary to heart failure.
We’ve launched a weekly provider-targeted podcast where cardiovascular physicians explore timely research and clinical developments shaping their practice.
Got a patient who’s curious about robotically assisted heart surgery? Share the essentials — and some reassurance — with this richly visual three-minute video.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Operative risk is low and survival is excellent regardless of whether the patient’s valve pathology is simple or complex. The findings may fuel a trend toward earlier surgical referrals.
As use of bioprosthetic mitral valves grows among ever-younger patients, more and more bioprostheses will fail. A new study gives guidance on selecting patients for evolving transcatheter valve-in-valve treatment options.
In this three-minute captioned video, Dr. Marc Gillinov brings clarity to three common questions surrounding surgical treatment of atrial fibrillation.
A new study identified genes and genetic variations associated with 12 loci linked to risk for atrial fibrillation. The result is a genome-wide catalog to facilitate follow-on investigations.
Five surgical techniques can repair 95 percent of degenerative mitral valves. Dr. Marc Gillinov reviews them in this five-minute captioned video.
The 2014 study report that gave an edge to valve replacement over repair for severe ischemic mitral regurgitation appears to have impacted real-world practice, a new analysis shows.